Autor segons l'article: Kunath A; Weiner J; Krause K; Rehders M; Pejkovska A; Gericke M; Biniossek ML; Dommel S; Kern M; Ribas-Latre A; Schilling O; Brix K; Stumvoll M; Klöting N; Heiker JT; Blüher M
Departament: Medicina i Cirurgia
Autor/s de la URV: Ribas Latre, Aleix
Paraules clau: Treatment Protease Obesity Metabolic disease Klk7 Kallikrein-related peptidase 7 Inhibitor Adipose tissue
Resum: Increased plasma and adipose tissue protease activity is observed in patients with type 2 diabetes and obesity. It has been proposed that specific proteases contribute to the link between obesity, adipose tissue inflammation and metabolic diseases. We have recently shown that ablation of the serine protease kallikrein-related peptidase 7 (Klk7) specifically in adipose tissue preserves systemic insulin sensitivity and protects mice from obesity-related AT inflammation. Here, we investigated whether whole body Klk7 knockout (Klk7−/−) mice develop a phenotype distinct from that caused by reduced Klk7 expression in adipose tissue. Compared to littermate controls, Klk7−/− mice gain less body weight and fat mass both under chow and high fat diet (HFD) feeding, are hyper-responsive to exogenous insulin and exhibit preserved adipose tissue function due to adipocyte hyperplasia and lower inflammation. Klk7−/− mice exhibit increased adipose tissue thermogenesis, which is not related to altered thyroid function. These data strengthen our recently proposed role of Klk7 in the regulation of body weight, energy metabolism, and obesity-associated adipose tissue dysfunction. The protective effects of Klk7 deficiency in obesity are likely linked to a significant limitation of adipocyte hypertrophy. In conclusion, our data indicate potential application of specific KLK7 inhibitors to regulate KLK7 activity in the development of obesity and counteract obesity-associated inflammation and metabolic diseases.
Àrees temàtiques: Pharmacology & pharmacy Medicine, research & experimental Medicine (miscellaneous) General biochemistry,genetics and molecular biology Ciencias sociales Biochemistry, genetics and molecular biology (miscellaneous) Biochemistry, genetics and molecular biology (all) Biochemistry & molecular biology
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
Adreça de correu electrònic de l'autor: aleix.ribas@urv.cat
Data d'alta del registre: 2023-02-18
Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
Enllaç font original: https://www.mdpi.com/2227-9059/9/2/131
Referència a l'article segons font original: Biomedicines. 9 (2): 1-20
Referència de l'ítem segons les normes APA: Kunath A; Weiner J; Krause K; Rehders M; Pejkovska A; Gericke M; Biniossek ML; Dommel S; Kern M; Ribas-Latre A; Schilling O; Brix K; Stumvoll M; Klöti (2021). Role of kallikrein 7 in body weight and fat mass regulation. Biomedicines, 9(2), 1-20. DOI: 10.3390/biomedicines9020131
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
DOI de l'article: 10.3390/biomedicines9020131
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2021
Tipus de publicació: Journal Publications